TISSEEL KIT VH 0.5 3000 UNIT
APROTININ : 3000 UNIT FIBRINOGEN (HUMAN) : 110 MG ANTIHEMOPHILIC FACTOR (HUMAN) : 50 UNIT CALCIUM CHLORIDE : .04 MMOL THROMBIN (BOVINE) : 500 UNIT PLASMAFIBRONECTIN (CIG) : 9 MG PLASMINOGEN : 120 MCG THROMBIN (BOVINE) : 4 UNIT PROTEIN : 130 MG · DIN 02017229 · OSTERREICHISCHES INSTITUT FUR HAEMODERIVATE GES M.B.H.
Health Canada status: CANCELLED POST MARKET
What is TISSEEL KIT VH 0.5?
TISSEEL KIT VH 0.5 3000 UNIT contains APROTININ : 3000 UNIT FIBRINOGEN (HUMAN) : 110 MG ANTIHEMOPHILIC FACTOR (HUMAN) : 50 UNIT CALCIUM CHLORIDE : .04 MMOL THROMBIN (BOVINE) : 500 UNIT PLASMAFIBRONECTIN (CIG) : 9 MG PLASMINOGEN : 120 MCG THROMBIN (BOVINE) : 4 UNIT PROTEIN : 130 MG. It is listed in the Health Canada Drug Product Database under DIN 02017229, held by OSTERREICHISCHES INSTITUT FUR HAEMODERIVATE GES M.B.H., supplied as POWDER FOR SOLUTION ; LIQUID for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 13-Sep-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02017229 |
|---|---|
| Brand name | TISSEEL KIT VH 0.5 |
| Generic / active ingredient | APROTININ : 3000 UNIT FIBRINOGEN (HUMAN) : 110 MG ANTIHEMOPHILIC FACTOR (HUMAN) : 50 UNIT CALCIUM CHLORIDE : .04 MMOL THROMBIN (BOVINE) : 500 UNIT PLASMAFIBRONECTIN (CIG) : 9 MG PLASMINOGEN : 120 MCG THROMBIN (BOVINE) : 4 UNIT PROTEIN : 130 MG |
| Manufacturer | OSTERREICHISCHES INSTITUT FUR HAEMODERIVATE GES M.B.H. |
| Strength | 3000 UNIT |
| Dosage form | POWDER FOR SOLUTION ; LIQUID |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | B02BD20 COMBINATIONS |
| AHFS class | 20:28.16 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 13-Sep-1998 |
| Original market date | 1992-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B02BD20 COMBINATIONS. 0 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TISSEEL KIT VH | 4 UNIT | JELLY | OSTERREICHISCHES INSTITUT FUR HAEMODERIVATE GES M.B.H. | CANCELLED POST MARKET | DIN 00677558 |
| TISSEEL KIT VH 1.0 | Strength | Powder For Solution , Liquid | OSTERREICHISCHES INSTITUT FUR HAEMODERIVATE GES M.B.H. 67 Industriestrasse Vienna -- Austria 1221 | CANCELLED POST MARKET | DIN 01949020 |
| TISSEEL KIT VH 1.0 | Strength | Powder For Solution , Kit , Liquid | BAXTER AG Industriestrasse 67 Vienna Saone Et Loire Austria 1220 | CANCELLED POST MARKET | DIN 02233273 |
| TISSEEL KIT VH 2.0 | 100 UNIT / 2 ML | KIT ; POWDER FOR SOLUTION ; LIQUID | BAXTER AG | CANCELLED POST MARKET | DIN 02233274 |
| TISSEEL KIT VH 2.0 | 9 MG | POWDER FOR SOLUTION | OSTERREICHISCHES INSTITUT FUR HAEMODERIVATE GES M.B.H. | CANCELLED POST MARKET | DIN 01949012 |
| TISSEEL KIT VH 5.0 | Strength | Powder For Solution | OSTERREICHISCHES INSTITUT FUR HAEMODERIVATE GES M.B.H. 67 Industriestrasse Vienna -- Austria 1221 | CANCELLED POST MARKET | DIN 01974327 |
| TISSEEL KIT VH 5.0 | Strength | Kit , Powder For Solution , Liquid | BAXTER AG Industriestrasse 67 Vienna Saone Et Loire Austria 1220 | CANCELLED POST MARKET | DIN 02233275 |
Who else supplies COMBINATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. COMBINATIONS appears in 5 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.